| Metric | Value (₹ Cr) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 2.0K | 3.5% | 12.2% |
| Total Income | 2.0K | 3.3% | 11.4% |
| Expenditure | 1.8K | 1.2% | 10.2% |
| PBT | 190.40 | 23.2% | 31.8% |
| Net Profit | 119.90 | 17.0% | 17.0% |
| OPM | 17.07% | 1.83pp | 18.76pp |
| NPM | 6.07% | 0.71pp | 0.29pp |
| EPS | 7.59 | 16.9% | 17.3% |
Jubilant Pharmova Ltd Announces Q2 and Half-Year Results for 2025
31 Oct 2025 · 31 Oct 2025, 01:05 pm
Summary
Jubilant Pharmova Ltd has announced its Q2 and half-year results for the year 2025. The company's standalone and consolidated financial results for the quarter and half-year ended September 30, 2025, have been approved by the Board of Directors.
Key Highlights
- 1
Revenue from operations for the quarter ended September 30, 2025, is 1,146 million.
- 2
Profit before tax for the quarter is 65 million.
- 3
Net profit for the period from continuing operations is (5-6) million.
- 4
Profit from discontinued operations is 17 million for the quarter.
- 5
Net profit for the period is (7+8) million.
- 6
Earnings per share for continuing operations is 1 (not annualized for the quarters).
- 7
Earnings per share for discontinued operations is 1 (not annualized for the quarters).
- 8
Earnings per share for total operations is 1 (not annualized for the quarters).
Informational and educational content only. Not investment advice.